Document Actions
Open Forum 3 — Key Issues in TB Drug Development
This two-day Open Forum was the third in a series of meetings aimed to raise and address key issues in TB drug development, with a special focus on regulatory affairs. Speaker presentations are now available for download.
The Forum included sessions on the current global TB drug development portfolio, key issues in the critical path to TB drug registration, designing pivotal trials, conducting registration trials in high burden countries, challenges in TB drug development for resistant disease and developing regimens containing multiple novel agents.
For a full agenda and all speakers presentations please visit the Open Forum 3 web page.